imatinib mesylate has been researched along with Enlarged Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Algahtani, FH; Alqahtany, FS | 1 |
| Całbecka, M; Gajkowska, J; Hałasz, M; Helbig, G; Hus, M; Krzemień, S; Markiewicz, M; Moskwa, A; Piszcz, J; Seferyńska, I; Swiderska, A; Urbanowicz, A; Woszczyk, D | 1 |
| Heaney, NB; Holyoake, TL | 1 |
1 review(s) available for imatinib mesylate and Enlarged Liver
| Article | Year |
|---|---|
What is new in chronic myeloid leukaemia?
Topics: Antineoplastic Agents; Aurora Kinases; Benzamides; Bone Marrow Transplantation; Dasatinib; Drug Resistance, Neoplasm; Hepatomegaly; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Piperazines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines; Splenomegaly; Thiazoles | 2007 |
2 other study(ies) available for imatinib mesylate and Enlarged Liver
| Article | Year |
|---|---|
Evaluation and characterisation of Chronic myeloid leukemia and various treatments in Saudi Arabia: A retrospective study.
Topics: Abdominal Pain; Adult; Age Factors; Female; Hepatomegaly; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Middle Aged; Retrospective Studies; Saudi Arabia; Sex Factors; Splenomegaly; Young Adult | 2020 |
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzamides; Cough; Female; Hepatomegaly; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Incidental Findings; Leukocyte Count; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Platelet Count; Poland; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; RNA, Messenger; RNA, Neoplasm; Splenomegaly; Young Adult | 2010 |